4//SEC Filing
Calvin Sandra 4
Accession 0001882909-25-000006
CIK 0001438533other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:23 PM ET
Size
5.1 KB
Accession
0001882909-25-000006
Insider Transaction Report
Form 4
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Transactions
- Sale
Common Stock
2025-12-15$36.00/sh−2,910$104,760→ 45,635 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001882909
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:23 PM ET
- Size
- 5.1 KB